|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments for non-cash items: | |||||
| Depreciation and amortization | |||||
| Change in fair value - Listed shares | |||||
| Change in fair value - Derivative warrant liability | |||||
| Interest - Convertible notes | |||||
| Gain on Derivative warrant liability settlement | |||||
| Change in fair value - Embedded derivative and deferred amount amortization | |||||
| Interest and accretion - Convertible notes | |||||
| Loss on convertible notes settlement | |||||
| Lac Guret Property acquisition | |||||
| Unrealized foreign exchange loss (gain) | |||||
| Loss on write-off/disposal of property, plant and equipment | |||||
| Share-based compensation | |||||
| Accretion included within financial costs | |||||
| Other accretions included within financial costs | |||||
| Net change in working capital | |||||
| Cash flows used in operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Additions to property, plant, and equipment, net of grants | |||||
| Restricted cash and deposits | |||||
| Grants received | |||||
| Cash flows used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from private placements | |||||
| Convertible notes issue costs | |||||
| Repayment of borrowings | |||||
| Repayment of lease liabilities | |||||
| Proceeds from the exercise of stock options | |||||
| Share issue costs | |||||
| Cash flows from financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the period | |||||
| Cash and cash equivalents at the end of the period | |||||
Loading...